Trends in Pharmacological Sciences 1999 - Abstracts
| Trends in Pharmacological Sciences 1999 | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Advances in vascular neuroeffector mechanisms. | Pharmaceuticals and cosmetics industries | Guimaraes, Serafim, Moura, Daniel | |||
| Airway epithelium: more than just a barrier!(response to G. Folkerts and F.P. Nijkamp, Trends in Pharmacological Science, vol. 19, p. 334, 1998) | Pharmaceuticals and cosmetics industries | Wessler, Ignaz, Kirkpatrick, Charles J., Racke, Kurt | |||
| Alzheimer's disease: the tacrine legacy. | Pharmaceuticals and cosmetics industries | Kelly, John S. | |||
| Are ion-exchange processes central to understanding drug-resistance phenomena? | Pharmaceuticals and cosmetics industries | Roepe, Paul D., Martiney, James A. | |||
| Calcium homeostasis in dystrophic muscle. | Pharmaceuticals and cosmetics industries | Ruegg, Urs T., Gillis, Jean-Marie | |||
| Channel-linked receptors - from subunits to novel drug targets. | Pharmaceuticals and cosmetics industries | Ahtee, Liisa, Tuominen, Raimo K. | |||
| Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. | Pharmaceuticals and cosmetics industries | Quirion, Remi, De Souza, Errol B., Mennicken, Francoise, Maki, Rich | |||
| Chromaffin cell mechanisms: understanding catecholamine storage and release. | Pharmaceuticals and cosmetics industries | O'Connor, Daniel T. | |||
| Clarke and Bond reply.(to Gerald Zernig and Alois Saria in this issue) | Pharmaceuticals and cosmetics industries | Clarke, William P., Bond, Richard P. | |||
| COPD: new developments and therapeutic opportunities.(chronic obstructive pulmonary disease) | Pharmaceuticals and cosmetics industries | Barnes, Peter J., Rogers, Duncan F. | |||
| Disclosing apoptosis in the CNS.(central nervous system) | Pharmaceuticals and cosmetics industries | Abbracchio, Maria P., Ongini, Ennio, Memo, Maurizio | |||
| Folkerts and Nijkamp reply.(response to I. Wessler and C.J. Kirkpatrick in this issue, p. 52) | Pharmaceuticals and cosmetics industries | Folkerts, Gert, Nijkamp, Frans | |||
| GABA(sub B) receptors make it to the top - as dimers. | Pharmaceuticals and cosmetics industries | Fritschy, Jean-Marc, Mohler, Hanns | |||
| GABA(sub B) receptors - the first 7TM heterodimers. | Pharmaceuticals and cosmetics industries | Jones, Kenneth A., Kaupmann, Klemens, Bettler, Bernhard, Marshall, Fiona H. | |||
| Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? | Pharmaceuticals and cosmetics industries | Bischoff, Serge, Bernasconi, Raymond, Mathivet, Pascal, Marescaux, Christian | |||
| Glutamate receptors and asthmatic airway disease. | Pharmaceuticals and cosmetics industries | Said, Sami I. | |||
| G protein regulation of adenylate cyclase. | Pharmaceuticals and cosmetics industries | Simonds, William F. | |||
| How do we make the most of undergraduate placements in industry?(Brief Article) | Pharmaceuticals and cosmetics industries | McQueen, Daniel, Day, Kate, Land, Ray | |||
| Human adrenoreceptor polymorphisms: evolving recognition of clinical importance. | Pharmaceuticals and cosmetics industries | Insel, Paul A., Buscher, Rainer, Herrmann, Volker | |||
| Idiopathic constipation: too few stools and too little knowledge. | Pharmaceuticals and cosmetics industries | Briejer, Michel R., Schuurkes, Jan A.J., Sarna, Sushil K. | |||
| Informatics: coming to grips with complexity.(Pharmainformatics: A Trends Guide) | Pharmaceuticals and cosmetics industries | Drews, Jurgen | |||
| Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery. | Pharmaceuticals and cosmetics industries | Gonzalez, Frank J., Gelboin, Harry V., Krausz, Kristopher W., Yang, Tian J. | |||
| Insight into adenosine receptor function using antisense and gene-knockout approaches. | Pharmaceuticals and cosmetics industries | Nyce, Jonathan W. | |||
| In vivo regulation of intraneuronal trafficking of G protein-coupled receptors for neurotransmitters.(includes related article on the subcellular compartmentalization of G protein-coupled receptors) | Pharmaceuticals and cosmetics industries | Bloch, Bertrand, Dumartin, Brigitte, Bernard, Veronique | |||
| Life on the edg.(Brief Article) | Pharmaceuticals and cosmetics industries | Lynch, Kevin R., Im, Dong-Soon | |||
| Neuronal cell death: a demise with different shapes.(Cover Story) | Pharmaceuticals and cosmetics industries | Manzo, Luigi, Nicotera, Pierluigi, Liest, Marcel | |||
| Neuropeptide Y feeding receptors: are multiple subtypes involved? | Pharmaceuticals and cosmetics industries | Inui, Akio | |||
| Neurotrophins and depression. | Pharmaceuticals and cosmetics industries | Altar, C. Anthony | |||
| NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.(nitroaspirins) | Pharmaceuticals and cosmetics industries | Soldato, Piero del, Sorrentino, Raffaella, Pinto, Aldo | |||
| One wheel on my wagon: lysolipid phosphate signalling. | Pharmaceuticals and cosmetics industries | Morris, Andrew J. | |||
| Online access to 'Trends in Pharmacological Sciences.'.(magazine)(Editorial) | Pharmaceuticals and cosmetics industries | ||||
| Protease-activated receptors: PAR4 and counting: how long is the course? | Pharmaceuticals and cosmetics industries | Hollenberg, Morley D. | |||
| Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning. | Pharmaceuticals and cosmetics industries | Helden, Herman P.M. van, Bueters, Tjerk J.H. | |||
| RAMPs: accessory proteins for seven transmembrane domain receptors.(receptor activity modifying proteins) | Pharmaceuticals and cosmetics industries | Foord, Steven M., Marshall, Fiona H. | |||
| Recent advances in the pharmacology of quaternary salts of bicuculine. | Pharmaceuticals and cosmetics industries | Johnson, Steven W., Seutin, Vincent | |||
| Selective COX-2 inhibitors: is the water becoming muddy?(cyclooxygenase) | Pharmaceuticals and cosmetics industries | Wallace, John L. | |||
| Stress-axis, coping and dementia: gene-manipulation studies. | Pharmaceuticals and cosmetics industries | Heinrichs, Stephen C. | |||
| The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes. | Pharmaceuticals and cosmetics industries | Strosberg, A. Donny, Issad, Tarik | |||
| The race to control pain: more participants, more targets. | Pharmaceuticals and cosmetics industries | Wnendt, Stephan, Chizh, Boris A., Dickenson, Anthony H. | |||
| The Vulcan kidney. | Pharmaceuticals and cosmetics industries | Waud, Douglas R. | |||
| TinyGRAP database: a bioinformatics tool to mine G-protein-coupled receptor mutant data. | Pharmaceuticals and cosmetics industries | Beukers, Margot W., Kristiansen, Kurt, IJzerman, Adriaan P., Edvardsen, Oyvind | |||
| Two novel families of ectonucleotidases: molecular structures, catalytic properties and a search for function. | Pharmaceuticals and cosmetics industries | Zimmermann, Herbert | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.